WordPress KBoard feed https://gtreepharma.com/en/wp-content/plugins/kboard/rss.php WordPress KBoard feed <![CDATA[ReGenTree Announces the Results of the ARISE-2 Trial With RGN-259 for the Treatment of Dry Eye: Significant Efficacies Were Con]]> Tue, 31 Oct 2017 16:18:07 +0000 Press Release <![CDATA[RegeneRx JV Presents Results of Phase 2b/3 (ARISE-1) Dry Eye Trial at ARVO 2017]]> Wed, 02 Aug 2017 14:06:41 +0000 Press Release <![CDATA[RegeneRx Licensee Receives FDA Permission to Conduct a Phase 3 Trial of RGN-137 for Epidermolysis Bullosa in U.S.]]> Tue, 28 Feb 2017 13:56:23 +0000 Press Release <![CDATA[RegeneRx Announces First Patients Enrolled in Phase 3 U.S. Dry Eye Clinical Trial (ARISE-2 Trial) with RGN-259]]> Wed, 30 Nov 2016 17:23:33 +0000 Press Release <![CDATA[RegeneRx Joint Venture to Begin Second Phase 3 Study Of RGN-259 for Dry Eye Syndrome in 3rd Quarter]]> Wed, 31 Aug 2016 10:32:52 +0000 Press Release <![CDATA[RGN-259 Confirms Efficacy in Signs and Symptoms of Dry Eye]]> Mon, 09 May 2016 13:12:38 +0000 Press Release <![CDATA[RegeneRx and ReGenTree Expand License for Dry Eye]]> Mon, 09 May 2016 13:11:49 +0000 Press Release <![CDATA[OKLAHOMA BRIEFS(Glioblastoma drug trials planned)]]> Fri, 19 Feb 2016 09:22:51 +0000 Press Release <![CDATA[GtreeBNT Acquires New Drug for the Treatment of Glioblastomas]]> Wed, 17 Feb 2016 09:37:25 +0000 Press Release <![CDATA[G-treeBNT announces resignation of co-CEO]]> Wed, 17 Feb 2016 09:37:07 +0000 Press Release <![CDATA[RegeneRx Announces Completion of Patient Enrollment In Phase 2b/3 U.S. Dry Eye Trial]]> Wed, 03 Feb 2016 09:46:22 +0000 Press Release <![CDATA[RegeneRx U.S. Joint Venture, ReGenTree, Launches Web Site]]> Wed, 03 Feb 2016 09:44:52 +0000 Press Release <![CDATA[RegeneRx Joint Venture Posts Results of Severe Dry Eye Trial On ClinicalTrials.gov]]> Fri, 22 Jan 2016 09:52:57 +0000 Press Release <![CDATA[RegeneRx Updates on U.S. Ophthalmic Clinical Trials]]> Thu, 26 Nov 2015 16:46:48 +0000 Press Release <![CDATA[RegeneRx Announces First Patient Enrolled in Phase 3 U.S. Neurotrophic Keratopathy (NK) Clinical Trial with RGN-259]]> Wed, 14 Oct 2015 17:51:27 +0000 Press Release <![CDATA[RegeneRx Announces First Patients Enrolled in Phase 2b/3 U.S. Dry Eye Clinical Trial with RGN-259]]> Wed, 14 Oct 2015 17:50:52 +0000 Press Release <![CDATA[GtreeBNT receives approval from FDA for phase 3 clinic trial for GBT-201/RGN-259]]> Tue, 15 Sep 2015 11:35:48 +0000 Press Release <![CDATA[GtreeBNT to start phase 3 trial for xerophthalmia medicine]]> Tue, 15 Sep 2015 11:35:23 +0000 Press Release <![CDATA[Gtree receives Korean approval to begin phase 2b/3 study of GBT-201 in patients with dry eye syndrome]]> Tue, 15 Sep 2015 11:34:55 +0000 Press Release <![CDATA[RegeneRx Korean Licensee Receives Government Approval to Conduct Phase 2b/3 Clinical Trial in Patients with Dry Eye Syndrome]]> Tue, 15 Sep 2015 11:34:33 +0000 Press Release